TheProfitWatch

SLNO - Soleno Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
63.74 2.97 (4.66%) --- --- -0.69 (-1.02%) --- 3.95 (6.2%) -0.99 (-1.46%) -0.99 (-1.46%)

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Category: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-741.2222
Diluted P/E:
-741.2222
RSI(14) 1m:
0.0
VWAP:
66.71
RVol:
0.4712

Events

Period Kind Movement Occurred At
1m Price increase 1m 65.96 +0.67 (+1.03%) Oct 15 11:40

Related News